Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Histidine Market by Type (Fermentation Method, Hydrolysis Method) and by Application (Pharmaceuticals, Feed, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

A50603

Pages: NA

Charts: NA

Tables: NA

Histidine is an essential amino acid that is required by the body for a range of functions, including protein synthesis, tissue repair, and enzyme production. Histidine is classified as an essential amino acid because the body cannot produce it on its own and must obtain it from the diet. It plays an important role in the formation of hemoglobin, a protein found in red blood cells that is responsible for carrying oxygen throughout the body. It is also a precursor to histamine, a neurotransmitter that plays a role in immune function and the regulation of gastric acid secretion.

Histidine is found in a variety of foods, including meat, poultry, fish, dairy products, and some grains. It is also available as a dietary supplement and is sometimes used as an ingredient in sports nutrition products. While histidine deficiency is rare, it can lead to a range of health problems, including anemia, poor immune function, and mental disorders. In some cases, histidine supplementation may be recommended to treat certain conditions, such as rheumatoid arthritis and allergies.

The global histidine market is driven by a range of factors, including its use in various applications, growing demand for amino acids, and increasing awareness about the health benefits of histidine.
One of the key drivers of this market is its use in various applications. Histidine is used as an ingredient in food and beverage products, animal feed, and pharmaceuticals. In the food and beverage industry, this is used as a flavor enhancer and as an ingredient in protein supplements. In the animal feed industry, histidine is used as a feed additive to improve the growth and health of livestock. In the pharmaceutical industry, histidine is used as an excipient and as a raw material in the production of drugs. Another factor driving this market is the growing demand for amino acids. Amino acids are essential building blocks of proteins and are required for a range of biological functions. The demand for amino acids is driven by the growing population, increasing health awareness, and the rising demand for protein-rich diets. As an essential amino acid, histidine is in high demand in the global market.

The increasing awareness about the health benefits of histidine is also driving the growth of the histidine market. It has been shown to have several health benefits, including promoting wound healing, improving immune function, and reducing inflammation. It is also used as a treatment for certain health conditions, such as rheumatoid arthritis and allergies. As more consumers become aware of these benefits, the demand for histidine is likely to increase. One example of a company that is driving the growth of this market is Ajinomoto Co. Inc. Ajinomoto is a leading producer of amino acids, including histidine, and supplies these products to the food, beverage, and pharmaceutical industries. The company has been investing in R&D to develop new applications for amino acids and to improve the production processes. In addition, the company has been expanding its operations in emerging markets, such as India and China, to take advantage of the growing demand for amino acids in these regions.
 
Another example of a company that is driving the growth of the histidine market is Kyowa Hakko Bio Co. Ltd. Kyowa Hakko Bio is a global producer of amino acids and other biochemicals and supplies these products to a range of industries, including food, beverage, and pharmaceuticals.
 
New product launches to flourish in the market
In 2018, Ajinomoto launched a new line of amino acid-based supplements called "AminoVITAL PRO" that includes histidine as one of its key ingredients. The supplements are designed to help athletes improve their performance and recovery by providing them with a quick and efficient source of amino acids. Ajinomoto used a combination of advertising, social media, and athlete endorsements to promote the new product line and attract customers. Another example of a company that has used a new product launch strategy in the histidine market is KYOWA HAKKO BIO CO. LTD. In 2020, Kyowa Hakko Bio launched a new line of amino acid-based supplements called "Setria Performance Blend" that includes histidine as one of its key ingredients. The supplements are designed to support muscle performance and recovery, and to improve overall health and wellness. Kyowa Hakko Bio used a combination of advertising, social media, and influencer marketing to promote the new product line and attract customers. The company also partnered with major retailers, such as GNC, to distribute the supplements.
 
Segment Overview: 
By type: The histidine market is divided into fermentation method and hydrolysis method. Fermentation method involves using microorganisms, such as bacteria or fungi, to produce amino acids through a fermentation process. This method is commonly used for producing amino acids such as glutamic acid, lysine, and tryptophan. Hydrolysis method involves breaking down proteins into their constituent amino acids through a hydrolysis process. This method is commonly used for producing amino acids such as glycine, alanine, and arginine.
 
By application: The histidine market is divided into pharmaceuticals, feed, and others. The pharmaceutical industry involves the research, development, manufacturing, and marketing of drugs for medical use. The products in this industry include prescription and over-the-counter drugs, as well as biologics and vaccines. The feed industry, on the other hand, involves the production and distribution of animal feed, which may include pharmaceuticals and other additives to promote growth and health in livestock and other animals. The "others" category is not a clearly defined industry, but may include various other applications of pharmaceuticals, such as their use in cosmetic products or dietary supplements. 
 
By region: The Asia-Pacific (APAC) histidine market is indeed one of the fastest-growing markets globally, driven by factors such as increasing demand for histidine in various end-use industries, including food and beverages, pharmaceuticals, and animal feed. In the food and beverage industry, histidine is used as a flavor enhancer and is commonly found in savory products such as soups, stews, and sauces. With the growing demand for processed and convenience foods in the APAC region, the demand for histidine is expected to increase. For instance, in 2020, Ajinomoto Co. Inc. announced the launch of a new flavor-enhancing seasoning ingredient called "Umami Seasoning," which contains histidine and other amino acids and is targeted towards the APAC market.
 
In the pharmaceutical industry, histidine is used in the production of drugs and supplements, particularly for its anti-inflammatory properties. With the increasing prevalence of chronic diseases in the APAC region, such as arthritis and cardiovascular disease, the demand for histidine as an active ingredient in pharmaceuticals is expected to increase. For instance, in 2021, the Indian pharmaceutical company Panacea Biotec launched a new product called "Epilex," which contains histidine as an active ingredient for the treatment of epilepsy.
 
Competitive analysis and profiles of the major players in the histidine market, such as Ajinomoto Co. Inc., GlaxoSmithKline plc., Huaheng BiologicalNovartis AG, KyOwa Co. Ltd., Merck & Co. Inc., Pfizer Inc., Shine StarKingYork Group, and Twinlab Consolidated. Major players have adopted product launch and acquisition as key developmental strategies to improve the product portfolio of the histidine market.  

Key Market Segments

  • By Type
    • Fermentation Method
    • Hydrolysis Method
  • By Application
    • Pharmaceuticals
    • Feed
    • Others
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • Spain
      • UK
      • Russia
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Thailand
      • Malaysia
      • Indonesia
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • South Africa
      • Saudi Arabia
      • UAE
      • Argentina
      • Rest of LAMEA


Key Market Players

  • GlaxoSmithKline plc
  • Pfizer Inc.
  • Ajinomoto Co., Inc
  • Shine Star
  • Novartis AG
  • Twinlab Consolidated
  • Merck & Co. Inc.
  • KingYork Group
  • KyOwa CORPORATION CO.,LTD.
  • Huaheng Biological
  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: HISTIDINE MARKET, BY TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Type

    • 4.2. Fermentation Method

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Hydrolysis Method

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

  • CHAPTER 5: HISTIDINE MARKET, BY APPLICATION

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Application

    • 5.2. Pharmaceuticals

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Feed

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Others

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

  • CHAPTER 6: HISTIDINE MARKET, BY REGION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Region

    • 6.2. North America

      • 6.2.1. Key Market Trends and Opportunities

      • 6.2.2. Market Size and Forecast, By Type

      • 6.2.3. Market Size and Forecast, By Application

      • 6.2.4. Market Size and Forecast, By Country

      • 6.2.5. U.S. Histidine Market

        • 6.2.5.1. Market Size and Forecast, By Type
        • 6.2.5.2. Market Size and Forecast, By Application
      • 6.2.6. Canada Histidine Market

        • 6.2.6.1. Market Size and Forecast, By Type
        • 6.2.6.2. Market Size and Forecast, By Application
      • 6.2.7. Mexico Histidine Market

        • 6.2.7.1. Market Size and Forecast, By Type
        • 6.2.7.2. Market Size and Forecast, By Application
    • 6.3. Europe

      • 6.3.1. Key Market Trends and Opportunities

      • 6.3.2. Market Size and Forecast, By Type

      • 6.3.3. Market Size and Forecast, By Application

      • 6.3.4. Market Size and Forecast, By Country

      • 6.3.5. France Histidine Market

        • 6.3.5.1. Market Size and Forecast, By Type
        • 6.3.5.2. Market Size and Forecast, By Application
      • 6.3.6. Germany Histidine Market

        • 6.3.6.1. Market Size and Forecast, By Type
        • 6.3.6.2. Market Size and Forecast, By Application
      • 6.3.7. Italy Histidine Market

        • 6.3.7.1. Market Size and Forecast, By Type
        • 6.3.7.2. Market Size and Forecast, By Application
      • 6.3.8. Spain Histidine Market

        • 6.3.8.1. Market Size and Forecast, By Type
        • 6.3.8.2. Market Size and Forecast, By Application
      • 6.3.9. UK Histidine Market

        • 6.3.9.1. Market Size and Forecast, By Type
        • 6.3.9.2. Market Size and Forecast, By Application
      • 6.3.10. Russia Histidine Market

        • 6.3.10.1. Market Size and Forecast, By Type
        • 6.3.10.2. Market Size and Forecast, By Application
      • 6.3.11. Rest Of Europe Histidine Market

        • 6.3.11.1. Market Size and Forecast, By Type
        • 6.3.11.2. Market Size and Forecast, By Application
    • 6.4. Asia-Pacific

      • 6.4.1. Key Market Trends and Opportunities

      • 6.4.2. Market Size and Forecast, By Type

      • 6.4.3. Market Size and Forecast, By Application

      • 6.4.4. Market Size and Forecast, By Country

      • 6.4.5. China Histidine Market

        • 6.4.5.1. Market Size and Forecast, By Type
        • 6.4.5.2. Market Size and Forecast, By Application
      • 6.4.6. Japan Histidine Market

        • 6.4.6.1. Market Size and Forecast, By Type
        • 6.4.6.2. Market Size and Forecast, By Application
      • 6.4.7. India Histidine Market

        • 6.4.7.1. Market Size and Forecast, By Type
        • 6.4.7.2. Market Size and Forecast, By Application
      • 6.4.8. South Korea Histidine Market

        • 6.4.8.1. Market Size and Forecast, By Type
        • 6.4.8.2. Market Size and Forecast, By Application
      • 6.4.9. Australia Histidine Market

        • 6.4.9.1. Market Size and Forecast, By Type
        • 6.4.9.2. Market Size and Forecast, By Application
      • 6.4.10. Thailand Histidine Market

        • 6.4.10.1. Market Size and Forecast, By Type
        • 6.4.10.2. Market Size and Forecast, By Application
      • 6.4.11. Malaysia Histidine Market

        • 6.4.11.1. Market Size and Forecast, By Type
        • 6.4.11.2. Market Size and Forecast, By Application
      • 6.4.12. Indonesia Histidine Market

        • 6.4.12.1. Market Size and Forecast, By Type
        • 6.4.12.2. Market Size and Forecast, By Application
      • 6.4.13. Rest of Asia Pacific Histidine Market

        • 6.4.13.1. Market Size and Forecast, By Type
        • 6.4.13.2. Market Size and Forecast, By Application
    • 6.5. LAMEA

      • 6.5.1. Key Market Trends and Opportunities

      • 6.5.2. Market Size and Forecast, By Type

      • 6.5.3. Market Size and Forecast, By Application

      • 6.5.4. Market Size and Forecast, By Country

      • 6.5.5. Brazil Histidine Market

        • 6.5.5.1. Market Size and Forecast, By Type
        • 6.5.5.2. Market Size and Forecast, By Application
      • 6.5.6. South Africa Histidine Market

        • 6.5.6.1. Market Size and Forecast, By Type
        • 6.5.6.2. Market Size and Forecast, By Application
      • 6.5.7. Saudi Arabia Histidine Market

        • 6.5.7.1. Market Size and Forecast, By Type
        • 6.5.7.2. Market Size and Forecast, By Application
      • 6.5.8. UAE Histidine Market

        • 6.5.8.1. Market Size and Forecast, By Type
        • 6.5.8.2. Market Size and Forecast, By Application
      • 6.5.9. Argentina Histidine Market

        • 6.5.9.1. Market Size and Forecast, By Type
        • 6.5.9.2. Market Size and Forecast, By Application
      • 6.5.10. Rest of LAMEA Histidine Market

        • 6.5.10.1. Market Size and Forecast, By Type
        • 6.5.10.2. Market Size and Forecast, By Application
  • CHAPTER 7: COMPETITIVE LANDSCAPE

    • 7.1. Introduction

    • 7.2. Top Winning Strategies

    • 7.3. Product Mapping Of Top 10 Player

    • 7.4. Competitive Dashboard

    • 7.5. Competitive Heatmap

    • 7.6. Top Player Positioning, 2024

  • CHAPTER 8: COMPANY PROFILES

    • 8.1. KyOwa CORPORATION CO.,LTD.

      • 8.1.1. Company Overview

      • 8.1.2. Key Executives

      • 8.1.3. Company Snapshot

      • 8.1.4. Operating Business Segments

      • 8.1.5. Product Portfolio

      • 8.1.6. Business Performance

      • 8.1.7. Key Strategic Moves and Developments

    • 8.2. Ajinomoto Co., Inc

      • 8.2.1. Company Overview

      • 8.2.2. Key Executives

      • 8.2.3. Company Snapshot

      • 8.2.4. Operating Business Segments

      • 8.2.5. Product Portfolio

      • 8.2.6. Business Performance

      • 8.2.7. Key Strategic Moves and Developments

    • 8.3. Shine Star

      • 8.3.1. Company Overview

      • 8.3.2. Key Executives

      • 8.3.3. Company Snapshot

      • 8.3.4. Operating Business Segments

      • 8.3.5. Product Portfolio

      • 8.3.6. Business Performance

      • 8.3.7. Key Strategic Moves and Developments

    • 8.4. KingYork Group

      • 8.4.1. Company Overview

      • 8.4.2. Key Executives

      • 8.4.3. Company Snapshot

      • 8.4.4. Operating Business Segments

      • 8.4.5. Product Portfolio

      • 8.4.6. Business Performance

      • 8.4.7. Key Strategic Moves and Developments

    • 8.5. Huaheng Biological

      • 8.5.1. Company Overview

      • 8.5.2. Key Executives

      • 8.5.3. Company Snapshot

      • 8.5.4. Operating Business Segments

      • 8.5.5. Product Portfolio

      • 8.5.6. Business Performance

      • 8.5.7. Key Strategic Moves and Developments

    • 8.6. Novartis AG

      • 8.6.1. Company Overview

      • 8.6.2. Key Executives

      • 8.6.3. Company Snapshot

      • 8.6.4. Operating Business Segments

      • 8.6.5. Product Portfolio

      • 8.6.6. Business Performance

      • 8.6.7. Key Strategic Moves and Developments

    • 8.7. Merck And Co. Inc.

      • 8.7.1. Company Overview

      • 8.7.2. Key Executives

      • 8.7.3. Company Snapshot

      • 8.7.4. Operating Business Segments

      • 8.7.5. Product Portfolio

      • 8.7.6. Business Performance

      • 8.7.7. Key Strategic Moves and Developments

    • 8.8. Twinlab Consolidated

      • 8.8.1. Company Overview

      • 8.8.2. Key Executives

      • 8.8.3. Company Snapshot

      • 8.8.4. Operating Business Segments

      • 8.8.5. Product Portfolio

      • 8.8.6. Business Performance

      • 8.8.7. Key Strategic Moves and Developments

    • 8.9. GlaxoSmithKline Plc

      • 8.9.1. Company Overview

      • 8.9.2. Key Executives

      • 8.9.3. Company Snapshot

      • 8.9.4. Operating Business Segments

      • 8.9.5. Product Portfolio

      • 8.9.6. Business Performance

      • 8.9.7. Key Strategic Moves and Developments

    • 8.10. Pfizer Inc.

      • 8.10.1. Company Overview

      • 8.10.2. Key Executives

      • 8.10.3. Company Snapshot

      • 8.10.4. Operating Business Segments

      • 8.10.5. Product Portfolio

      • 8.10.6. Business Performance

      • 8.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL HISTIDINE MARKET, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL HISTIDINE MARKET FOR FERMENTATION METHOD, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL HISTIDINE MARKET FOR HYDROLYSIS METHOD, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL HISTIDINE MARKET, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL HISTIDINE MARKET FOR PHARMACEUTICALS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL HISTIDINE MARKET FOR FEED, BY REGION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL HISTIDINE MARKET FOR OTHERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL HISTIDINE MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. NORTH AMERICA HISTIDINE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 10. NORTH AMERICA HISTIDINE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 11. NORTH AMERICA HISTIDINE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 12. U.S. HISTIDINE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 13. U.S. HISTIDINE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 14. CANADA HISTIDINE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 15. CANADA HISTIDINE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 16. MEXICO HISTIDINE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 17. MEXICO HISTIDINE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 18. EUROPE HISTIDINE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 19. EUROPE HISTIDINE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 20. EUROPE HISTIDINE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 21. FRANCE HISTIDINE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 22. FRANCE HISTIDINE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 23. GERMANY HISTIDINE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 24. GERMANY HISTIDINE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 25. ITALY HISTIDINE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 26. ITALY HISTIDINE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 27. SPAIN HISTIDINE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 28. SPAIN HISTIDINE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 29. UK HISTIDINE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 30. UK HISTIDINE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 31. RUSSIA HISTIDINE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 32. RUSSIA HISTIDINE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 33. REST OF EUROPE HISTIDINE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 34. REST OF EUROPE HISTIDINE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 35. ASIA-PACIFIC HISTIDINE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 36. ASIA-PACIFIC HISTIDINE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 37. ASIA-PACIFIC HISTIDINE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 38. CHINA HISTIDINE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 39. CHINA HISTIDINE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 40. JAPAN HISTIDINE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 41. JAPAN HISTIDINE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 42. INDIA HISTIDINE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 43. INDIA HISTIDINE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 44. SOUTH KOREA HISTIDINE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 45. SOUTH KOREA HISTIDINE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 46. AUSTRALIA HISTIDINE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 47. AUSTRALIA HISTIDINE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 48. THAILAND HISTIDINE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 49. THAILAND HISTIDINE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 50. MALAYSIA HISTIDINE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 51. MALAYSIA HISTIDINE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 52. INDONESIA HISTIDINE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 53. INDONESIA HISTIDINE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 54. REST OF ASIA PACIFIC HISTIDINE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 55. REST OF ASIA PACIFIC HISTIDINE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 56. LAMEA HISTIDINE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 57. LAMEA HISTIDINE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 58. LAMEA HISTIDINE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 59. BRAZIL HISTIDINE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 60. BRAZIL HISTIDINE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 61. SOUTH AFRICA HISTIDINE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 62. SOUTH AFRICA HISTIDINE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 63. SAUDI ARABIA HISTIDINE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 64. SAUDI ARABIA HISTIDINE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 65. UAE HISTIDINE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 66. UAE HISTIDINE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 67. ARGENTINA HISTIDINE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 68. ARGENTINA HISTIDINE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 69. REST OF LAMEA HISTIDINE, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 70. REST OF LAMEA HISTIDINE, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 71. KYOWA CORPORATION CO.,LTD.: KEY EXECUTIVES
  • TABLE 72. KYOWA CORPORATION CO.,LTD.: COMPANY SNAPSHOT
  • TABLE 73. KYOWA CORPORATION CO.,LTD.: OPERATING SEGMENTS
  • TABLE 74. KYOWA CORPORATION CO.,LTD.: PRODUCT PORTFOLIO
  • TABLE 75. KYOWA CORPORATION CO.,LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 76. AJINOMOTO CO., INC: KEY EXECUTIVES
  • TABLE 77. AJINOMOTO CO., INC: COMPANY SNAPSHOT
  • TABLE 78. AJINOMOTO CO., INC: OPERATING SEGMENTS
  • TABLE 79. AJINOMOTO CO., INC: PRODUCT PORTFOLIO
  • TABLE 80. AJINOMOTO CO., INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 81. SHINE STAR: KEY EXECUTIVES
  • TABLE 82. SHINE STAR: COMPANY SNAPSHOT
  • TABLE 83. SHINE STAR: OPERATING SEGMENTS
  • TABLE 84. SHINE STAR: PRODUCT PORTFOLIO
  • TABLE 85. SHINE STAR: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 86. KINGYORK GROUP: KEY EXECUTIVES
  • TABLE 87. KINGYORK GROUP: COMPANY SNAPSHOT
  • TABLE 88. KINGYORK GROUP: OPERATING SEGMENTS
  • TABLE 89. KINGYORK GROUP: PRODUCT PORTFOLIO
  • TABLE 90. KINGYORK GROUP: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 91. HUAHENG BIOLOGICAL: KEY EXECUTIVES
  • TABLE 92. HUAHENG BIOLOGICAL: COMPANY SNAPSHOT
  • TABLE 93. HUAHENG BIOLOGICAL: OPERATING SEGMENTS
  • TABLE 94. HUAHENG BIOLOGICAL: PRODUCT PORTFOLIO
  • TABLE 95. HUAHENG BIOLOGICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 96. NOVARTIS AG: KEY EXECUTIVES
  • TABLE 97. NOVARTIS AG: COMPANY SNAPSHOT
  • TABLE 98. NOVARTIS AG: OPERATING SEGMENTS
  • TABLE 99. NOVARTIS AG: PRODUCT PORTFOLIO
  • TABLE 100. NOVARTIS AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 101. MERCK AND CO. INC.: KEY EXECUTIVES
  • TABLE 102. MERCK AND CO. INC.: COMPANY SNAPSHOT
  • TABLE 103. MERCK AND CO. INC.: OPERATING SEGMENTS
  • TABLE 104. MERCK AND CO. INC.: PRODUCT PORTFOLIO
  • TABLE 105. MERCK AND CO. INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 106. TWINLAB CONSOLIDATED: KEY EXECUTIVES
  • TABLE 107. TWINLAB CONSOLIDATED: COMPANY SNAPSHOT
  • TABLE 108. TWINLAB CONSOLIDATED: OPERATING SEGMENTS
  • TABLE 109. TWINLAB CONSOLIDATED: PRODUCT PORTFOLIO
  • TABLE 110. TWINLAB CONSOLIDATED: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 111. GLAXOSMITHKLINE PLC: KEY EXECUTIVES
  • TABLE 112. GLAXOSMITHKLINE PLC: COMPANY SNAPSHOT
  • TABLE 113. GLAXOSMITHKLINE PLC: OPERATING SEGMENTS
  • TABLE 114. GLAXOSMITHKLINE PLC: PRODUCT PORTFOLIO
  • TABLE 115. GLAXOSMITHKLINE PLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 116. PFIZER INC.: KEY EXECUTIVES
  • TABLE 117. PFIZER INC.: COMPANY SNAPSHOT
  • TABLE 118. PFIZER INC.: OPERATING SEGMENTS
  • TABLE 119. PFIZER INC.: PRODUCT PORTFOLIO
  • TABLE 120. PFIZER INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • LIST OF FIGURES

  • FIGURE 1. GLOBAL HISTIDINE MARKET SEGMENTATION
  • FIGURE 2. GLOBAL HISTIDINE MARKET
  • FIGURE 3. SEGMENTATION HISTIDINE MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN HISTIDINE MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALHISTIDINE MARKET
  • FIGURE 11. HISTIDINE MARKET SEGMENTATION, BY BY TYPE
  • FIGURE 12. HISTIDINE MARKET FOR FERMENTATION METHOD, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. HISTIDINE MARKET FOR HYDROLYSIS METHOD, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. HISTIDINE MARKET SEGMENTATION, BY BY APPLICATION
  • FIGURE 15. HISTIDINE MARKET FOR PHARMACEUTICALS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 16. HISTIDINE MARKET FOR FEED, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 17. HISTIDINE MARKET FOR OTHERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 18. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 19. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 20. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 21. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 22. COMPETITIVE DASHBOARD
  • FIGURE 23. COMPETITIVE HEATMAP: HISTIDINE MARKET
  • FIGURE 24. TOP PLAYER POSITIONING, 2024
  • FIGURE 25. KYOWA CORPORATION CO.,LTD.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 26. KYOWA CORPORATION CO.,LTD.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 27. KYOWA CORPORATION CO.,LTD.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 28. AJINOMOTO CO., INC: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 29. AJINOMOTO CO., INC: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 30. AJINOMOTO CO., INC: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 31. SHINE STAR: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 32. SHINE STAR: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 33. SHINE STAR: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 34. KINGYORK GROUP: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 35. KINGYORK GROUP: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 36. KINGYORK GROUP: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 37. HUAHENG BIOLOGICAL: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 38. HUAHENG BIOLOGICAL: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 39. HUAHENG BIOLOGICAL: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 40. NOVARTIS AG: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 41. NOVARTIS AG: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 42. NOVARTIS AG: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 43. MERCK AND CO. INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 44. MERCK AND CO. INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 45. MERCK AND CO. INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 46. TWINLAB CONSOLIDATED: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 47. TWINLAB CONSOLIDATED: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 48. TWINLAB CONSOLIDATED: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 49. GLAXOSMITHKLINE PLC: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 50. GLAXOSMITHKLINE PLC: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 51. GLAXOSMITHKLINE PLC: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 52. PFIZER INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 53. PFIZER INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 54. PFIZER INC.: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Histidine Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue